We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Stability of Hematological Parameters Tested In Blood Collection Systems

By LabMedica International staff writers
Posted on 26 Oct 2010
The integrity of a hematological sample is known to depend on time and temperature and the measurement technique has already been found to have an impact on stability.

Two specimen tubes containing an anticoagulant were tested for their affect on the stability of hematological parameters overtime. More...
Full blood count and reticulocyte hematological analyses were conducted on a Beckman Coulter LH750 hematology analyzer (Beckman Coulter, Inc, Brea, CA, USA), at multiple time points up to 72 hours.

The two blood collection systems tested were the Vacutainer from Becton Dickinson, (BD; Franklin Lakes, NJ USA) and the Monovette from Sarstedt Inc., (Newton, NC, USA). In a recent study carried out by Icon Development Solutions (Manchester, UK), twenty healthy volunteers (10 males, 10 females) were recruited. No restrictions were placed on these volunteers. A total of 36.9 mL blood was taken from each volunteer, collected using a cannula into seven 2.7 mL ethylenediaminetetraacetic acid (EDTA) Sarstedt Monovettes and four 4.5 mL EDTA BD Vacutainers. Both types of tube are plastic and contain tri-potassium (K3) EDTA as an anticoagulant. Becton Dickinson tubes contain 7.2 mg K3 EDTA in a 4 mL tube; Sarstedt tubes contain sufficient K3 EDTA to achieve a concentration of 1.2-2 mg EDTA/mL blood, with a maximum dilution effect of 1%.

All parameters matched or exceeded Beckman Coulter stated stability values, with both Sarstedt and BD tubes showing remarkably similar levels of stability for all parameters. The exceptions were that mean platelet volume (MPV) was only stable for 18 hours in BD tubes and 24 hours in Sarstedt tubes, and neutrophils (NE) were stable for 72 hours in BD tubes, but only 48 hours in Sarstedt tubes. However, it was noted that the degradation of the Sarstedt samples appears to be more predictable and follows a much more linear pattern. Accurate full blood count results can be obtained on samples up to 48 hours, provided that the samples are stored in a refrigerator. The tube type was found to have minimal impact on the stability of hematological samples. The study was published in October 2010 in the British Journal of Biomedical Science.

Related Links:
Beckman Coulter
Becton Dickinson
Sarstedt
Icon Development Solutions


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Automatic Western Blot Analyzer
Tenfly Phoenix Blot Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.